The Most Complete and Accurate Human Growth Hormone Guide in the World
HGH » HGH Articles » HGH For Fibromyalgia
HGH For Fibromyalgia
Read the Following article on "HGH For Fibromyalgia".
Positive Effects of the Human Growth Hormone on people suffering from Fibromyalgia
Fibromyalgia also called fibrositis, is characterized by muscular pain and muscle fatigue. The main symptoms of fibromyalgia are chronic widespread pain, non-existence of another factor that could cause the pain, and various starting points in the soft tissue causing indications of the disease. Unclear, non specific muscular pain is characteristic of fibromyalgia. Women are more prone to the disorder.
In 1991, Bennett recognized that HGH levels were low in fibromyalgia patients. He was able to prove that growth hormone given to these patients daily, for nine months, could improve the symptoms of the disorder. Fibromyalgia patients demonstrate reduced levels of IGF-1 due to stress, sleep disturbances and muscle fatigue. As time passes, the symptoms aggravate. It is also studied that low levels of the growth hormone might enhance the muscle pain and fatigue in fibromyalgia. Administration of the growth hormone to patients as an experiment was made at Oregon Health Sciences University by Dr. Bennett’s team. This hormone treatment turned out to be vastly successful. Improvement in the symptoms of fibromyalgia was observed within six months of GH treatment, but significant results were observed only after nine months. However, when the therapy was discontinued, the symptoms were back. Improvement was seen in patients taking not only injections, but also other forms of this hormone. Since, HGH is released during deep sleep and during exercise, people observed reduced effects of fibromyalgia during exercise and sleep.
In fibromyalgia patients, there appears to be other hormone imbalances associated as well. Cortisol, IGF-1, neuropeptide-Y and leptin have also been incriminated.
There was a case in which a person suffering from fibromyalgia met with an accident and this greatly aggravated the disease condition. He became both physically and mentally weak. He embarked on GH therapy and wonderful results were observed after the treatment for taken for eight weeks.
In the past, it has been found that about thirty percent of fibromyalgia patients possess low levels of IGF-1 and hence, low GH too. As they lack these sources to repair the body, they suffer from severe pain and discomfort. Fibromyalgia sufferers, who took the drug Mestinon, were observed to have higher levels of the GH and IGF-1 after an interval of six months. This drug stops the function of Somatostatin which is the inhibitor of GHRH (growth hormone releasing hormone) and enhances the secretion of the hormone considerably.
Fibromyalgia also called fibrositis, is characterized by muscular pain and muscle fatigue. The main symptoms of fibromyalgia are chronic widespread pain, non-existence of another factor that could cause the pain, and various starting points in the soft tissue causing indications of the disease. Unclear, non specific muscular pain is characteristic of fibromyalgia. Women are more prone to the disorder.
In 1991, Bennett recognized that HGH levels were low in fibromyalgia patients. He was able to prove that growth hormone given to these patients daily, for nine months, could improve the symptoms of the disorder. Fibromyalgia patients demonstrate reduced levels of IGF-1 due to stress, sleep disturbances and muscle fatigue. As time passes, the symptoms aggravate. It is also studied that low levels of the growth hormone might enhance the muscle pain and fatigue in fibromyalgia. Administration of the growth hormone to patients as an experiment was made at Oregon Health Sciences University by Dr. Bennett’s team. This hormone treatment turned out to be vastly successful. Improvement in the symptoms of fibromyalgia was observed within six months of GH treatment, but significant results were observed only after nine months. However, when the therapy was discontinued, the symptoms were back. Improvement was seen in patients taking not only injections, but also other forms of this hormone. Since, HGH is released during deep sleep and during exercise, people observed reduced effects of fibromyalgia during exercise and sleep.
In fibromyalgia patients, there appears to be other hormone imbalances associated as well. Cortisol, IGF-1, neuropeptide-Y and leptin have also been incriminated.
There was a case in which a person suffering from fibromyalgia met with an accident and this greatly aggravated the disease condition. He became both physically and mentally weak. He embarked on GH therapy and wonderful results were observed after the treatment for taken for eight weeks.
In the past, it has been found that about thirty percent of fibromyalgia patients possess low levels of IGF-1 and hence, low GH too. As they lack these sources to repair the body, they suffer from severe pain and discomfort. Fibromyalgia sufferers, who took the drug Mestinon, were observed to have higher levels of the GH and IGF-1 after an interval of six months. This drug stops the function of Somatostatin which is the inhibitor of GHRH (growth hormone releasing hormone) and enhances the secretion of the hormone considerably.